1. Home
  2. INGM vs BLCO Comparison

INGM vs BLCO Comparison

Compare INGM & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INGM
  • BLCO
  • Stock Information
  • Founded
  • INGM 1979
  • BLCO 1853
  • Country
  • INGM United States
  • BLCO Canada
  • Employees
  • INGM N/A
  • BLCO N/A
  • Industry
  • INGM
  • BLCO Ophthalmic Goods
  • Sector
  • INGM
  • BLCO Health Care
  • Exchange
  • INGM NYSE
  • BLCO Nasdaq
  • Market Cap
  • INGM 5.5B
  • BLCO 5.6B
  • IPO Year
  • INGM 2024
  • BLCO 2022
  • Fundamental
  • Price
  • INGM $17.68
  • BLCO $14.08
  • Analyst Decision
  • INGM Strong Buy
  • BLCO Hold
  • Analyst Count
  • INGM 14
  • BLCO 11
  • Target Price
  • INGM $26.69
  • BLCO $19.10
  • AVG Volume (30 Days)
  • INGM 505.0K
  • BLCO 610.2K
  • Earning Date
  • INGM 03-04-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • INGM 0.41%
  • BLCO N/A
  • EPS Growth
  • INGM N/A
  • BLCO N/A
  • EPS
  • INGM 1.18
  • BLCO N/A
  • Revenue
  • INGM $47,983,671,000.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • INGM $5.37
  • BLCO $6.53
  • Revenue Next Year
  • INGM $3.78
  • BLCO $5.64
  • P/E Ratio
  • INGM $15.21
  • BLCO N/A
  • Revenue Growth
  • INGM N/A
  • BLCO 15.56
  • 52 Week Low
  • INGM $17.75
  • BLCO $13.16
  • 52 Week High
  • INGM $25.69
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • INGM N/A
  • BLCO 25.79
  • Support Level
  • INGM N/A
  • BLCO $13.88
  • Resistance Level
  • INGM N/A
  • BLCO $15.77
  • Average True Range (ATR)
  • INGM 0.00
  • BLCO 0.43
  • MACD
  • INGM 0.00
  • BLCO -0.11
  • Stochastic Oscillator
  • INGM 0.00
  • BLCO 6.36

About INGM INGRAM MICRO HOLDING CORPORATION

Ingram Micro Holding Corp is a technology company for the global information technology ecosystem. It plays a vital role in the IT sales channel, bringing products and services from technology manufacturers and cloud providers to business-to-business technology experts. The company also provide a broad range of technology services, including financing, specialized marketing, and lifecycle management, as well as technical pre- and post-sales professional support.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: